Publications

5891 Results

Paclitaxel-gemcitabine (P-G) for patients (pts) with advanced (adv) urothelial cancer (UC), aged > 70 years 9yrs): SWOG 0028

Authors
D Raghavan;C Tangen;C Moinpour;C Gotay;K Albain;S Louie;HJ Lenz;DI Quinn;MHA Hussain;IM Thompson
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr 4569); ASCO 2010 Meeting; poster
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
S0028

A phase II trial of biweekly gemcitabine and paclitaxel (GEMTAX) with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN): A Southwest Oncology Group study

Authors
KE Bickel;J Moon;O Kucuk;RH Wheeler;S Urba;G Wolf;FP Worden
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr 5555); ASCO 2010 Meeting; poster
Year
2010
Research Committee(s)
Head and Neck
Study Number(s)
S0329

Circulating tumor cell capture and analysis in a multi-center SWOG-coordinated prostate cancer trial

Authors
A Goldkorn;T Xu;B Lu;A Williams;LM Fink;C Tangen;YC Tai;DI Quinn;P Twardowski;RJ Cote
Journal / Conference
Journal of Clinical Oncology 28:7s, 2010 (suppl;abstr TPS342); ASCO; poster
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
S0421

Randomized phase II trial of sorafenib (SO) with temsirolimus (TEM) or tipifarnib (TIPI) in metastatic melanoma: Southwest Oncology Group trial S0438

Authors
K Margolin;J Moon;L Flaherty;C Lao;W Akerley;J Sosman;J Kirkwood;V Sondak
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr 8502); ASCO 2010 Meeting; oral
Year
2010
Research Committee(s)
Melanoma
Study Number(s)
S0438

A randomized phase II trial of combination gemcitabine + erlotinib + IMC-A12 (cixutumumab) vs. gemcitabine + erlotinib as first-line treatment in patients (pts) with metastatic pancreatic cancer: Southwest Oncology Group Study (SWOG S0727)

Authors
PA Philip;B Goldman;RK Ramanathan;HJ Lenz;AM Lowy;RP Whitehead;S Iqbal;V Chung;J Benedetti;CD Blanke
Journal / Conference
Journal of Clinical Oncology 28:7s (suppl; abstr TPS223); poster
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
S0727

Potential tumor biologic causes of the racial survival disparity in ER-positive breast cancer adjuvant trials

Authors
S Albain;W Barlow;S Shak;G Hortobagyi;D Hayes
Journal / Conference
Journal of Clinical Oncology 28:72s(suppl; abstr 511); oral
Year
2010
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

Southwest Oncology Group (SWOG) trial S9917: Randomized phase 3 trial of selenium supplementation to prevent prostate cancer among men with high grade prostatic intraepithelial neoplasia (HGPIN)

Authors
J Marshall;C Tangen;W Sakr;DP Wood;S Lippman;D Jarrad;DS Alberts;DL Berry;ED Crawford;IM Thompson
Journal / Conference
American Urological Association Annual Meeting; late breaking, oral
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
S9917

Southwest Oncology Group study 9921: prolonged event free survival in high risk prostate cancer (PC) patients receiving adjuvant androgen deprivation

Authors
IM Thompson;CM Tangen;MHA Hussain;DP Wood;G Swanson;DI Quinn;TB Dorff;NA Dawson;NB Haas;ED Crawford;LM Glode
Journal / Conference
American Urological Association 2010 Meeting; late breaking; oral
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
S9921

Cell cycle regulatory protein alterations in a randomized clinical trial of adjuvant chemotherapy following radical cystectomy and pelvic lymphadenectomy

Authors
SP Lerner;W Stadler;S Groshen;J Cai;A Mitra;E Tuazon;D Skinner;D Raghavan;D Esrig;G Steinberg;C Hall;RJ Cote
Journal / Conference
Journal of Urology 183(4):suppl.E662(abstr #1715); AUA 2010 Meeting (poster)
Year
2010
Research Committee(s)
Genitourinary
Study Number(s)
4B951

A phase II study to measure response rate and toxicity of neoadjuvant chemoradiotherapy with oxaliplatin (OX) and infusional 5-fluorouracil (5-fU) plus cetuximab followed by post-operative docetaxel cetuximab in patients with operable adenocarcinoma of the esophagus [E2205]

Authors
MK Gibson;L Kleinberg;C Staley;P Catalano;F Song;MF Mulcahy;LP Leichman;LB Benson
Journal / Conference
Journal of Clinical Oncology 28:7s(suppl;abstr 4064); poster presentation
Year
2010
Research Committee(s)
Gastrointestinal